Giagnoni G, Parolaro D, Sala M, Marabini L, Senini R, Gori E
Eur J Pharmacol. 1982 Apr 8;79(1-2):101-4. doi: 10.1016/0014-2999(82)90579-9.
Loperamide given intracerebroventricularly and intraperitoneally to rats provoked, like morphine, a plasma corticosterone increase 60 min after injection. Loperamide intracerebroventricularly was 3.73 times less active than morphine, while intraperitoneally it was 10.13 times more potent. This increase, associated with a significant elevation in the plasma ACTH concentration, was antagonized by naloxone (10 mg/kg i.p.) injected 30 min before loperamide. In hypophysectomized rats loperamide intraperitoneally did not affect the plasma corticosterone levels. We conclude that loperamide can stimulate corticosterone secretin from the adrenal gland via the opiate receptors and that this effect is mediated by a direct or indirect induction of ACTH release.
给大鼠脑室内和腹腔内注射洛哌丁胺,与吗啡一样,注射后60分钟可引起血浆皮质酮增加。脑室内注射的洛哌丁胺活性比吗啡低3.73倍,而腹腔内注射时其效力则强10.13倍。这种增加与血浆促肾上腺皮质激素(ACTH)浓度的显著升高相关,在洛哌丁胺注射前30分钟注射纳洛酮(10 mg/kg腹腔注射)可拮抗这种增加。在垂体切除的大鼠中,腹腔内注射洛哌丁胺不影响血浆皮质酮水平。我们得出结论,洛哌丁胺可通过阿片受体刺激肾上腺分泌皮质酮,且这种作用是由ACTH释放的直接或间接诱导介导的。